🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: GSK Biologicals' 10-valent pneumococcal conjugate vaccine.

Found 24 matching trials

A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study

PHASE3

Evaluate lot-to-lot consistency, safety and reactogenicity of 3 doses of GS...

Status

Completed

Location

GSK Investigational Site

Start Date

2005-11

Trial ID

NCT00307554

Treatments Being Tested

Pneumococcal (vaccine)

Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka

N/A

This PMS study aims to collect safety and reactogenicity data of Synflorix™...

Status

Withdrawn

Location

Multiple Locations

Start Date

2013-04

Trial ID

NCT01803425

Treatments Being Tested

Synflorix™ data collection

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

PHASE3

This study will evaluate safety, reactogenicity and immunogenicity of GSK B...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-08-07

Trial ID

NCT00344318

Treatments Being Tested

Pneumococcal conjugate vaccine GSK1024850A Prevenar Tritanrix-HepB Hiberix Polio Sabin.Poliorix.

COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine

PHASE3

This is a study in a large number of healthy children less than 3 years old...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-06-28

Trial ID

NCT00466947

Treatments Being Tested

Pneumococcal conjugate vaccine GSK1024850A Havrix Engerix-B Infanrix hexa GSK Biologicals' DTPa-IPV/Hib vaccine

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

PHASE2

This study will evaluate the safety and immunogenicity of GSK Biologicals' ...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-08-13

Trial ID

NCT00970307

Treatments Being Tested

GSK2202083A vaccine 10-valent pneumococcal vaccine (GSK 1024850A)Infanrix hexa™Menjugate®

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

PHASE3

This study will evaluate the safety, reactogenicity and immunogenicity of a...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-09-25

Trial ID

NCT00370396

Treatments Being Tested

Synflorix Prevenar Infanrix hexa

Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population

PHASE1

As the licensed pneumococcal vaccine is not always satisfactory in elderly,...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-05-01

Trial ID

NCT00327665

Treatments Being Tested

11-valent pneumococcal vaccine GSK513026 Pneumo 23™Placebo 10-valent pneumococcal vaccine GSK513026

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants

PHASE2

This study will assess the safety, reactogenicity and immunogenicity of two...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-09-27

Trial ID

NCT01204658

Treatments Being Tested

Pneumococcal vaccine GSK 2189242A (LD formulation 1)Pneumococcal vaccine GSK 2189242A (HD formulation 2)Synflorix Prevenar 13 Infanrix Hexa (DTPa-HBV-IPV/Hib)

A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

PHASE3

The primary aim of the study is to demonstrate that an investigational 4-do...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-06-11

Trial ID

NCT02447432

Treatments Being Tested

Pneumococcal vaccine GSK1024850A (10Pn-PD-DiT) vaccine (4-dose presentation)Pneumococcal vaccine GSK1024850A (10Pn-PD-DiT) vaccine (1-dose presentation)DTPw-HBV/Hib

Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea

N/A

The purpose of this study is to collect safety information following routin...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-12

Trial ID

NCT01248988

Treatments Being Tested

Synflorix™ Data collection

Previous Next